Diagnosis and treatment of uveitis by non-ophthalmologist physicians

Diagnóstico y tratamiento inicial de la uveítis por médicos no oftalmólogos

Published 2017-11-01

Open | Download
PDF (Spanish) FLIP application/xml XML (Spanish)
Issue
Vol. 15 No. 28 (2017)
Section
Artículo Original
How to Cite
Toro Arango, O., De la Torre, A., Pachón Suárez, D., Salazar Muñoz, J., & Parra Morales, A. M. (2017). Diagnosis and treatment of uveitis by non-ophthalmologist physicians. NOVA, 15(28), 99-114. https://doi.org/10.22490/24629448.2085
DOI

https://doi.org/10.22490/24629448.2085
Dimensions
PlumX
license

Licencia Creative Commons

NOVA by http://www.unicolmayor.edu.co/publicaciones/index.php/nova is distributed under a license creative commons non comertial-atribution-withoutderive 4.0 international.

Furthermore, the authors keep their property intellectual rights over the articles.

 

O Toro Arango
    A De la Torre
      D Pachón Suárez
        J Salazar Muñoz
          A M Parra Morales
            Show authors biography
            Objective: The purpose of this study was to describe the main diagnostic features and the initial management of uveitis, in order to avoid delays in the treatment and the remission to the ophthalmologist. Methods: A systematic review of the literature, which identified the main signs and symptoms and initial treatment for patients with uveitis, was done. A search of the literature published through 2010-2015 was performed using PubMed database. Four hundred and thirty nine eligible articles underwent a selection process in which titles, abstracts and full texts were reviewed, obtaining thirty final articles. Results: Thirty articles were reviewed, six were observational studies and clinical trials; 24 articles were reviews or case reports. The observational studies and clinical trials were rated with the Grading of Recommendations Assessment (GRADE) tool. After the grading tree of the articles were of high level of evidence. Conclusions: In a patient with ocular pain related to decreased visual acuity, photophobia, red eye without secretion, miosis, keratic precipitates, and vitritis or chorioretinitis the healthcare provider should rule out the diagnosis of uveitis. A non ophthalmologist physician can start the initial management of an anterior uveitis and then refer the patient to the ophthalmologist as soon as possible. If the diagnosis is an infectious anterior uveitis, intermediate uveitis or posterior uveitis the patient should be derived to the ophthalmologist immediately.

            Article visits 211 | PDF visits 166

            Downloads

            Download data is not yet available.
            1. REFERENCIAS
            2. Alañon FJ, Fernandez J FS. Oftalmología en la atención primaria. 1ra ed. Editorial Alcala, editor. Madrid; 2001. 177-198 p.
            3. Tasman W, Jaeger. EA. Duane’s Ophthalmology. Journal of Chemical Information and Modeling. 2009.
            4. Yanoff M, Duker J. Opthalmology. Mechanisms of Uveitis. 2nd ed. Edinburgo: Elsevier; 2009. 778-780 p.
            5. Borges S. Oftalmología [Internet]. 1 ed La habana. [cited 2012 Mar 8]. Available from: http://www.hospitalameijeiras.sld.cu/hha/mpm/documentos/OFTALMOLOGIA/PA/UVEITIS.pdf
            6. Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol [Internet]. 2007;55(3):173–83. Available from: http://www.ijo.in/article.asp?issn=0301-4738;year=2007;volume=55;issue=3;spage=173;epage=183;aulast=Rathinamnhttp://www.
            7. ncbi.nlm.nih.gov/pubmed/17456933
            8. De-la-Torre A, Lopez-Castillo CA, Rueda JC, Mantilla RD, Gomez-Marin JE, Anaya JM. Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia. Clin Exp Ophthalmol. 2009;37(5):458–66.
            9. Yanoff M, Duker J. Anatomy of the Uvea. Edinburgo: Elsevier; 2009. 775-776 p.
            10. Foxman EFE, Zhang M, Hurst SD, Muchamuel T, Shen D, Wawrousek EF, et al. Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol [Internet]. 2002;168(5):2483–92. Available from: http://www.jimmunol.org/content/168/5/2483.shortnhttp://www.ncbi.nlm.nih.gov/pubmed/11859142
            11. Li Z, Lim WK, Mahesh SP, Liu B, Nussenblatt RB. Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J Immunol [Internet]. 2005;174(9):5187–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15843513
            12. Chan CC, Li Q. Immunopathology of uveitis. Br J Ophthalmol [Internet]. 1998 Jan [cited 2016 Sep 8];82(1):91–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9536890
            13. Whitcup SM, Chan CC, Li Q, Nussenblatt RB. Expression of cell adhesion molecules in posterior uveitis. Arch Ophthalmol (Chicago, Ill 1960) [Internet]. 1992 May [cited 2016 Sep 8];110(5):662–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1374609
            14. Chan C-C, Gery I. Mechanisms of uveitis. 3rd ed. Elsevier; 1992.
            15. Rosa, JR R. 2015-2016 Basic and Clinical Science Course (bcsc): Ophthalmic Pathology and Intraocular Tumors. Section 4. Ophthalmology AA of, editor. 2015.
            16. Zhou R, Caspi RR. Ocular immune privilege. F1000 Biol Rep [Internet]. 2010 [cited 2016 Sep 8];2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20948803
            17. Taylor AW, Kaplan HJ. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis. Ocul Immunol Inflamm [Internet]. 2010 Dec [cited 2016 Sep 8];18(6):488– 92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21091058
            18. Smith JR, Jabs DA, Briceland DJ, Holland GN. Education in the ophthalmic discipline of uveitis. Am J Ophthalmol [Internet]. 2008 Dec [cited 2016 Sep 8];146(6):799–801. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19027419
            19. Nussenblatt RB, Whitcup SM. Uveitis: Fundamentals and Clinical Practice. 4rd ed. Chicago: Elsevier; 2010.
            20. FT K. Uveitis Infecciosa: Una Revisión. Arch Soc Esp Oftalmol [Internet]. 2000; Available from: http://www.oftalmo.com/seo/2000/04abr00/04.htm
            21. McCluskey PJ, Towler HM, Lightman S. Management of chronic uveitis. BMJ [Internet]. 2000 Feb 26 [cited 2016 Sep 8];320(7234):555–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10688564
            22. De Smet MD, Taylor SRJ, Bodaghi B, Miserocchi E, Murray PI, Pleyer U, et al. Understanding uveitis: The impact of research on visual outcomes. Prog Retin Eye Res [Internet]. 2011;30(6):452–70. Available from: http://dx.doi.org/10.1016/j.preteyeres.2011.06.005
            23. Herbort CP. Uveitis update: An overview by the society for Ophthalmo-Immunoinfectiology in Europe. Middle East Afr J Ophthalmol [Internet]. 2009 Oct [cited 2016 Sep 8];16(4):157–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20404983
            24. Chipont BE, Cunningham E. Manejo del paciente con uveítis anterior aguda. Arch Soc Esp Oftalmol [Internet]. 2002;4. Available from: http://www.oftalmo.com/seo/2002/04abr02/04.htm
            25. Weinberg R. Anterior uveitis. Ophtalmol clin North Am.1993;6:23–8.
            26. LeHoang P. The gold standard of noninfectious uveitis: Corticosteroids. New Treat Noninfectious Uveitis. 2012;51:7–28.
            27. Gomes Bittencourt M, Sepah YJ, Do D V, Agbedia O, Akhtar A, Liu H, et al. New treatment options for noninfectious uveitis. Dev Ophthalmol [Internet]. 2012 [cited 2016 Sep 8];51:134–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22517211
            28. Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmol J Int d’ophtalmologie Int J Ophthalmol Zeitschrift für Augenheilkd [Internet]. [cited 2016 Sep 8];218(4):223–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15258410
            29. Pato E, Muñoz-Fernández S, Francisco F, Abad MA, Maese J, Ortiz A, et al. Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis. Semin Arthritis Rheum [Internet]. 2011 Feb [cited 2016 Sep 8];40(4):314–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20656330
            30. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations
            31. of an expert panel. Am J Ophthalmol [Internet]. 2000 Oct [cited 2016 Sep 8];130(4):492–513. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11024423
            32. Larson T, Nussenblatt RB, Sen HN. Emerging drugs for uveitis. Expert Opin Emerg Drugs [Internet]. 2011 Jun [cited 2016 Sep 8];16(2):309–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21210752
            33. Hedayatfar A, Hashemi H, Asgari S, Chee S-P. Comparison of efficacy and ocular surface toxicity of topical preservative-free methylprednisolone and preserved prednisolone in the treatment
            34. of acute anterior uveitis. Cornea. 2014;33(4):366–72.
            35. Gallego-Pinazo R, Dolz-Marco R, Martínez-Castillo S, Arévalo JF, Díaz-Llopis M. Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis. Inflamm Allergy Drug Targets [Internet]. 2013;12(October 2015):38–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23441991
            36. Kruh J, Stephen Foster C. The philosophy of treatment of uveitis: Past, present and future. New Treat Noninfectious Uveitis. 2012;51:1–6.
            37. Siddique SS, Shah R, Suelves AM, Foster CS. Road to remission: a comprehensive review of therapy in uveitis. Expert Opin Investig Drugs [Internet]. 2011;20(11):1497–515. Available
            38. from: http://www.ncbi.nlm.nih.gov/pubmed/21936708
            39. Lee K, Bajwa A, Freitas-Neto CA, Metzinger JL, Wentworth BA, Foster CS. A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: Part II. Expert Opin Biol Ther [Internet]. 2014;14(11):1651–66. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L600509390nhttp://dx.doi.org/10.1517/14712598.2014.947957nhttp://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=17447682&id=-doi:10.1517/14712598.2014.947957&atitle=A+comprehensive+rev
            40. Pleyer U, Stübiger N. New pharmacotherapy options for noninfectious posterior uveitis. Expert Opin Biol Ther [Internet]. 2014;14(12):1783–99. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84910074151&partnerID=tZOtx3y1
            41. Dhoot DS, Martin DF, Srivastava SK. Pediatric infectious posterior uveitis. Int Ophthalmol Clin [Internet]. 2011;51(1):113–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21139480
            42. Mandelcorn ED. Infectious causes of posterioruveitis. Can J Ophthalmol [Internet]. 2013;48(1):31–9. Available from: http://dx.doi.org/10.1016/j.jcjo.2012.11.013
            43. Jap A, Chee S-P. Viral anterior uveitis. Curr Opin Ophthalmol. 2011;22(6):483–8.
            44. Barisani-Asenbauer T, Maca SM, Mejdoubi L, Emminger W, Machold K, Auer H. Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients. Orphanet J Rare Dis. 2012;7(1):57.
            45. Camilo ENR, Moura GL, Arantes TE, ª, e nio F. Clinical and epidemiological characteristics of patients with uveitis in an emergency eye care center in Brazil^ien; Caracterí
            46. sticas clínicas e epidemioló-gicas das uveítes em um serviço de urg&. Arq Bras Oftalmol [Internet]. 2014;2(1):3. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&ampnpid=S0004-2749201400010003
            47. Pan J, Kapur M, McCallum R. Noninfectious immune-me diated uveitis and ocular inflammation. Curr Allergy Asthma Rep. 2014;14(1):1–8.
            48. Velu J, Agarwal S, Gupta V, Sharma K, Sharma A, Gupta A. Hypopyon uveitis-a rare presentation of intraocular tuberculosis. Ocul Immunol Inflamm [Internet]. 2013;21(3):251– 3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23617801
            49. Cohen AE, Assang C, Patane MA, From S, Korenfeld M. Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis. Ophthalmology
            50. [Internet]. 2012;119(1):66–73. Available from: http://dx.doi.org/10.1016/j.ophtha.2011.07.006
            51. Sheppard JD, Toyos MM, Kempen JH, Kaur P, Foster CS. Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: A phase III, multicenter, randomized
            52. study. Investig Ophthalmol Vis Sci. 2014;55(5):2993–3002.
            53. Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: The multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118(10):1916–26.
            54. Selmi C. Diagnosis and classification of autoimmune uveitis. Autoimmun Rev. 2014;13(4–5):591–4.
            55. Khairallah M, Kahloun R, Ben Yahia S, Jelliti B, Messaoud R. New infectious etiologies for posterior uveitis. Ophthalmic Res. 2013;49(2):66–72.
            56. De Smet MD, Taylor SRJ, Bodaghi B, Miserocchi E, Murray PI, Pleyer U, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res [Internet]. 2011 Nov [cited 2016 Sep 8];30(6):452–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21807112
            57. Srivastava A, Rajappa M, Kaur J. Uveitis: Mechanisms and recent advances in therapy. Clin Chim Acta [Internet]. 2010;411(17–18):1165–71. Available from: http://dx.doi.org/10.1016/j.cca.2010.04.017
            58. Babu K, Mahendradas P. Medical management of uveitis - current trends. Indian J Ophthalmol [Internet]. 2013;61(6):277–83. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3744780&tool=pmcentrez&
            59. rendertype=abstract
            60. Majumder PD, Sudharshan S, Biswas J. Laboratory support in the diagnosis of uveitis. Indian J Ophthalmol [Internet]. 2013;61(6):269–76. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3744779&tool=pmcentrez&
            61. rendertype=abstract
            62. Kim SJ. Diagnosis and management of noninfectious pediatric uveitis. Int Ophthalmol Clin. 2011;51(1):129–45.
            63. Zierhut M, Deuter C, Murray PI. Classification of Uveitis – Current Guidelines. Eur Ophthalmic Rev [Internet]. 2007 [cited 2016 Sep 20];0(0):77. Available from: http://www.touchophthalmology.com/articles/classification-uveitis-current-guidelines
            64. Nausa, J. G. Evaluación Clínica y radiográfica de injertos biocerámicos tipo Hidroxiapatita como alternativa en la reconstrucción de alveolos dentarios postexodoncia. NOVA. 2014; 12(22).
            65. Flórez, R. A. N. Avances y perspectivas en Síndrome de Asperger. 2014; Nova, 12(21).
            66. Rodríguez, O. E., Andrade, W. A., Díaz, F. E., & Moncada, B. Actividad antimicrobiana de líquenes de la cuenca alta del rio Bogotá. 2015; Nova, 13(23).
            67. DOI: http://dx.doi.org/10.22490/24629448.2085
            Tutorials

            Autors:

            How send article?

            Evaluator pair

            How to evaluate an article?

            Information

            Keywords

            Google Scholar profile

            Is part of
             
            Más leídos en los últimos 30 días

            Current Issue

            Sistema OJS 3.4.0.5 - Metabiblioteca |